Actively Recruiting
Rapid Response Teams - How and Who? A Randomized Controlled Trial Examining the Composition of the RRT in a General Hospital
Led by Nordsjaellands Hospital · Updated on 2025-09-17
1500
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate how different Rapid Response Teams (RRT) are composed in a hospital setting. It compares a Critical Care Outreach Team (CCOT), consisting of an ICU-trained nurse along with a ward physician and nurse, to a Medical Emergency Team (MET), which includes an ICU doctor and nurse plus a ward physician and nurse. The trial is investigator-initiated, randomized, and one-sided blinded, focusing on whether the CCOT is not worse than the MET in managing patients needing rapid response. Patients who deteriorate will be randomly assigned to either the CCOT or MET when a rapid response is called. The CCOT team is led by the ward physician with the ICU nurse attending, while the MET team is led by an ICU doctor and nurse. Each team records details of the event in the patient's electronic medical record. Randomization is done using sealed envelopes with allocation concealed from investigators but known to clinicians involved in care. Participants will be followed for outcomes including mortality, cardiac arrest, unplanned ICU admissions, and unexpected death up to 30 days after the rapid response event. Additional measures include activation of escape protocols, end-of-life care initiation, time spent bedside, and length of hospital stay. Data collection includes hospital records and national registries. Outcomes are assessed blinded to treatment groups, and safety monitoring may lead to unblinding if necessary. The study duration includes follow-up at 30 and 90 days post-randomization.
CONDITIONS
Brief Title
Rapid Response Teams - How and Who?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Admitted to any general ward of the hospital
- Aged 63 18 years
- In need of Rapid Response Team attention
You will not qualify if you...
- Age < 18 years
- Admitted to the delivery ward
- Admitted to any ward in the anesthetic department including ICU, High Dependency Unit, Post Operation Department, Operating Theatre, Same Day Admissions - Surgery Ward
- Not admitted at the time of call, including evaluation track in Emergency department, Out-Patient departments, X-ray department
- Any patient who cannot be randomized at the time of call
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Screening occurs prior to Rapid Response Team activation.
Duration - Approximately 45 minutes per Rapid Response Team event
Participants receive care from a Rapid Response Team composed either of an ICU Nurse with ward physician and nurse (experimental) or an ICU Doctor and ICU Nurse with ward physician and nurse (control) when deterioration occurs.
Rapid Response Team activation and intervention occur at the time of patient deterioration; multiple activations possible during admission.
Duration - Up to 90 days post randomization
Participants are followed for outcomes including mortality and other clinical events up to 90 days after the Rapid Response Team event.
Follow-up through hospital records and registries, no additional visits required
Trial Site Locations
Total: 1 location
1
Nordsjællands Hospital
Hillerød, Danmark, Denmark, 3400
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here